首页> 外文期刊>Lipids in Health Disease >Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition, and changes in the metabolic profile of obese patients following 3-week body mass reduction program: a randomized clinical trial
【24h】

Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition, and changes in the metabolic profile of obese patients following 3-week body mass reduction program: a randomized clinical trial

机译:油菜籽油或苋菜种子油补充对3周体重减少计划后体重减轻,身体成分和肥胖患者代谢剖面性的影响的比较:随机临床试验

获取原文
       

摘要

Amaranth seed oil (ASO) and rapeseed oil (RSO) are functional foods that display antioxidant and hepatoprotective properties. These oils are also known to lower glucose and cholesterol levels. The current study compared the effects exerted by RSO and ASO on weight loss and metabolic parameters during a 3-week body mass reduction program. Eighty-one obese subjects (BMI??30?kg/m2), aged 25–70?years, were enrolled in a 3-week body mass reduction program based on a calorie-restricted diet and physical activity. Participants were randomly categorized into an AO group (administered 20?mL/d of ASO), a RO group (administered 20?mL/d of RSO), and a C group (control; untreated). Anthropometric and metabolic parameters were measured at baseline and endpoint. Significant decreases in weight, body mass index (BMI), waist circumference (WC), hip circumference (HC), fat mass (FM), lean body mass (LBM), visceral fat mass (VFM), and total body water (TBW%) were observed in all groups (P? 0.05). No significant improvements were observed in the clinical parameters of group C. Fasting insulin (Δ ??5.9, and Δ ??5.7) and homeostatic model assessment of insulin resistance (HOMA-IR) (Δ ??1.1 and Δ ??0.5) were decreased in both RO and AO groups, respectively. Fasting glucose (Δ -8.5; P?=?0.034), total cholesterol (Δ -14.6; P?=?0.032), non-HDL cholesterol (Δ 15.9; P?=?0.010), TG/HDL ratio (Δ -0.6; P?=?0.032), LDL cholesterol (Δ -12.3; P?=?0.042), and triglycerides (Δ -6.5; P?=?0.000) were significantly improved in the AO group, compared to the RO group. The 3-week body mass reduction intervention caused a significant reduction in the weight, BMI, WC, HC, FM, and VFM of all groups. Except for HOMA-IR, there were no statistical differences between the clinical parameters of all groups. However, a trend toward improved insulin levels and HDL% was noticeable in AO and RO. Therapies involving edible oils with high nutritional value, such as RSO and ASO, show potential for improving metabolic measurements during body mass reduction programs. Thus, obese patients undertaking weight reduction programs may benefit from RSO and ASO supplementation. retrospectively registered, DRKS00017708.
机译:苋菜种子油(ASO)和菜籽油(RSO)是展示抗氧化剂和肝保护性能的功能性食品。这些油还已知降低葡萄糖和胆固醇水平。目前的研究比较了RSO和ASO在3周体重减少计划期间对体重减轻和代谢参数进行的效果。八十一肥胖的主题(BMI ?????????????????????????????????????>将参与者随机分类为AO组(施用20?ML / D的ASO),RO组(施用20μl/ d的RSO)和C组(对照;未经处理)。在基线和终点下测量人体计量和代谢参数。重量,体重指数(BMI),腰围(WC),髋周(HC),脂肪质量(FM),瘦体质量(LBM),内脏脂肪质量(VFM)和总体水(TBW在所有基团中观察到%)(p?<0.05)。 C组临床参数中没有观察到显着的改进。禁食胰岛素(Δ-? 5.9和δ≤1.7)和胰岛素抵抗的稳态模型评估(Δω1.1和Δ0.5)分别在罗和AO组中减少。空腹葡萄糖(δ-8.5; p?= 0.034),总胆固醇(δ-14.6; p?= 0.032),非HDL胆固醇(δ15.9; p?=Δ010),Tg / HDL比率(δ - 0.6; p?= 0.032),LDL胆固醇(δ-12.3; p?= 0.042),与RO组相比,在AO组中,在AO组中显着改善甘油三酯(Δ-6.5;p≤0.000)。 3周的体重减少干预导致所有组的重量,BMI,WC,HC,FM和VFM显着降低。除HOMA-IR外,所有群体的临床参数之间没有统计学差异。然而,在AO和RO中,改善胰岛素水平和HDL%的趋势是显着的。涉及具有高营养价值的食用油的疗法,例如RSO和ASO,显示出在体重减少计划期间改善代谢测量的可能性。因此,进行减肥计划的肥胖患者可能会受益于rso和aso补充。追溯注册,DRKS00017708。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号